In this issue:
- Respiratory disorders among adult Aboriginal Australians
- Microbial dysregulation of the gut-lung axis in bronchiectasis
- Beclomethasone-formoterol for chronic cough in non-CF bronchiectasis
- Nebulised vs. intravenous tranexamic acid for haemoptysis
- Gefapixant for refractory or unexplained chronic cough
- Bronchiectasis in Europe
- Treatment preferences and reducing treatment burden for CF
- Discontinuing hypertonic saline or dornase alfa in CFTR modulator-treated CF
- Chest physiotherapy for CF
- Vanzacaftor-tezacaftor-deutivacaftor for adult CF
Please login below to download this issue (PDF)